Loading...
CleanSpace Holdings Limited
CSX.AX•ASX
Healthcare
Medical - Devices
A$0.79
A$0.03(3.27%)
CleanSpace Holdings Limited (CSX.AX) Financial Performance & Income Statement Overview
Access detailed quarterly and annual financial reports for CleanSpace Holdings Limited (CSX.AX), covering cash flow, earnings, and balance sheets.
Revenue Growth
30.01%
↑ 30.01%
Operating Income Growth
59.98%
↑ 59.98%
Net Income Growth
61.54%
↑ 61.54%
Operating Cash Flow Growth
85.56%
↑ 85.56%
Operating Margin
-14.88%
↓ 14.88%
Gross Margin
73.82%
↑ 73.82%
Net Profit Margin
-8.39%
↓ 8.39%
ROE
-7.76%
↓ 7.76%
ROIC
-11.89%
↓ 11.89%
CleanSpace Holdings Limited (CSX.AX) Income Statement & Financial Overview
View the income breakdown for CleanSpace Holdings Limited CSX.AX across both annual and quarterly reports.
| Metric | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $9.18M | $8.43M | $7.29M | $6.37M |
| Cost of Revenue | $2.35M | $2.26M | $7.32M | $8.02M |
| Gross Profit | $6.83M | $6.16M | -$27162.00 | -$1.66M |
| Gross Profit Ratio | $0.74 | $0.73 | -$0.004 | -$0.26 |
| R&D Expenses | $310686.00 | $977024.00 | $318114.00 | $253869.00 |
| SG&A Expenses | $7.00M | $6.89M | $2.78M | $2.83M |
| Operating Expenses | $7.77M | $7.85M | $3.10M | $3.08M |
| Total Costs & Expenses | $10.11M | $10.11M | $10.42M | $11.10M |
| Interest Income | $0.00 | $287110.00 | $221581.00 | $142354.00 |
| Interest Expense | $0.00 | $92224.00 | $94607.00 | $108361.00 |
| Depreciation & Amortization | $462987.00 | $11284.00 | $470365.00 | $512399.00 |
| EBITDA | -$472414.00 | -$1.67M | -$2.44M | -$4.22M |
| EBITDA Ratio | -$0.05 | -$0.20 | -$0.33 | -$0.66 |
| Operating Income | -$935401.00 | -$1.68M | -$3.13M | -$4.73M |
| Operating Income Ratio | -$0.10 | -$0.20 | -$0.43 | -$0.74 |
| Other Income/Expenses (Net) | $115579.00 | $97444.00 | $126974.00 | $27467.00 |
| Income Before Tax | -$819822.00 | -$1.59M | -$3.002M | -$4.71M |
| Income Before Tax Ratio | -$0.09 | -$0.19 | -$0.41 | -$0.74 |
| Income Tax Expense | -$415588.00 | $514278.00 | -$948129.00 | -$1.32M |
| Net Income | -$404234.00 | -$1.07M | -$2.05M | -$3.39M |
| Net Income Ratio | -$0.04 | -$0.13 | -$0.28 | -$0.53 |
| EPS | -$0.005 | -$0.01 | -$0.03 | -$0.04 |
| Diluted EPS | -$0.005 | -$0.01 | -$0.03 | -$0.04 |
| Weighted Avg Shares Outstanding | $77.74M | $77.19M | $77.22M | $77.03M |
| Weighted Avg Shares Outstanding (Diluted) | $77.74M | $77.24M | $77.22M | $77.03M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan